Publications by authors named "Elizabeth T Masters"

Claim this Profile
P
Patient experience and unmet needs in high-risk nonmuscle-invasive bladder cancer: Insights from qualitative interviews and a cross-sectional survey.
Lewis Kopenhafer, Allison Thompson, Jane Chang, Slaven Sikirica, Elizabeth T Masters

Urol Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and outcomes in PD-L1-positive non-small cell lung cancer.
Xinke Zhang, Richard W DeClue, Lisa Herms, Mo Yang, Vivek Pawar, Elizabeth T Masters

Immunotherapy· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost-Effectiveness of Lorlatinib Versus Chemotherapy as a Second- or Third-Line Treatment in Anaplastic Lymphoma Kinase (ALK)-Positive Non-small-cell Lung Cancer in Sweden.
Fredrik O L Nilsson, Sandra T Asanin, Elizabeth T Masters, Laura Iadeluca, Chrissy Almond

Pharmacoeconomics· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer.
David M Waterhouse, Janet L Espirito, Marc D Chioda, Bismark Baidoo, Jack Mardekian, Elizabeth T Masters

Drugs Real World Outcomes· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews.
Lauren J Lee, Christina S Kwon, Anna Forsythe, Carla M Mamolo, Elizabeth T Masters

Clinicoecon Outcomes Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study.
Yasushi Goto, Nobuyuki Yamamoto, Elizabeth T Masters, Hironori Kikkawa, Jack Mardekian

Adv Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer.
Solange Peters, Alice T Shaw, Benjamin Besse, Enriqueta Felip, Benjamin J Solomon, Elizabeth T Masters

Lung Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural Language Processing-Identified Problem Opioid Use and Its Associated Health Care Costs.
Elizabeth T Masters, Arvind Ramaprasan, Jack Mardekian, Roy E Palmer, David E Gross

J Pain Palliat Care Pharmacother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of sequencing of ALK inhibitors in -positive non-small-cell lung cancer.
Stephanie M Barrows, Kelly Wright, Catherine Copley-Merriman, James A Kaye, Marc Chioda, Elizabeth T Masters

Lung Cancer (Auckl)· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer.
Yi-Long Wu, Shun Lu, You Lu, Jianying Zhou, Yuan-Kai Shi, Elizabeth T Masters

J Thorac Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of opioid medication abuse with and without tampering in the USA.
Jeffrey Vietri, Elizabeth T Masters, Alexandra I Barsdorf, Jack Mardekian

Clinicoecon Outcomes Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Use and Outcomes of ALK-Positive Crizotinib-Treated Metastatic NSCLC in US Community Oncology Practices: A Retrospective Observational Study.
Craig Reynolds, Elizabeth T Masters, Jenny Black-Shinn, Marley Boyd, Jack Mardekian

J Clin Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Educational intervention for physicians to address the risk of opioid abuse.
Margaret K Pasquale, Richard L Sheer, Jack Mardekian, Elizabeth T Masters, Nick C Patel

J Opioid Manag· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing Risk Assessment in Patients Receiving Chronic Opioid Analgesic Therapy Using Natural Language Processing.
Irina V Haller, Colleen M Renier, Mitch Juusola, Paul Hitz, William Steffen, Elizabeth T Masters

Pain Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain.
Arnold J Weil, Elizabeth T Masters, Alexandra I Barsdorf, Almasa Bass, Glenn Pixton

Health Qual Life Outcomes· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of the effectiveness of policies restricting access to pregabalin.
Brett R Stacey, Jonathan Liss, Regina Behar, Alesia Sadosky, Bruce Parsons, Elizabeth T Masters

BMC Health Serv Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration.
Jody L Green, Becki Bucher Bartelson, M Claire Le Lait, Carl L Roland, Elizabeth T Masters

Drug Alcohol Depend· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Guideline-recommended Pain Medication Use Among Patients with Newly Diagnosed Fibromyalgia.
Rachel Halpern, Sonali N Shah, Joseph C Cappelleri, Elizabeth T Masters, Andrew Clair

Pain Pract· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and Work Loss Burden of Diagnosed Opioid Abuse Among Employees on Workers Compensation or Short-term Disability.
Stephen S Johnston, Andrea H Alexander, Elizabeth T Masters, Jack Mardekian, David Semel

J Occup Environ Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating increased resource use in fibromyalgia using electronic health records.
Jay M Margolis, Elizabeth T Masters, Joseph C Cappelleri, David M Smith, Steven Faulkner

Clinicoecon Outcomes Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibromyalgia Outcomes Over Time: Results from a Prospective Observational Study in the United States.
Caroline P Schaefer, Edgar H Adams, Margarita Udall, Elizabeth T Masters, Rachael M Mann

Open Rheumatol J· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Burden of Prescription Opioid Misuse and Abuse: A Systematic Review.
Gary M Oderda, Joanita Lake, Katja Rüdell, Carl L Roland, Elizabeth T Masters

J Pain Palliat Care Pharmacother· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of illness in fibromyalgia patients with comorbid depression.
Lucinda Bateman, Piercarlo Sarzi-Puttini, Claire L Burbridge, Jaren W Landen, Elizabeth T Masters

Clin Exp Rheumatol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of fibromyalgia: results from a 2-year observational fibromyalgia and chronic pain study in the US.
Edgar H Adams, Heather J McElroy, Margarita Udall, Elizabeth T Masters, Rachael M Mann

J Pain Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using natural language processing to identify problem usage of prescription opioids.
David S Carrell, David Cronkite, Roy E Palmer, Kathleen Saunders, David E Gross, Elizabeth T Masters

Int J Med Inform· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis